Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 10 - 27 tags : Treatment save search
UPDATE – Sorrento Announces Encouraging Results From Two Phase 2 Studies of Abivertinib For Treatment Of Hospitalized Severe COVID-19 Patients
Published: 2021-10-27 (Crawled : 20:00) - globenewswire.com
SRNE | $0.015 -8.85% 56K
|
Health Technology
|
| O: 0.3%
H: 5.22%
C: 5.07%
covid treatment phase 2 results
Sorrento Announces Encouraging Results From Two Phase 2 Studies of Abivertinib For Treatment Of Hospitalized Severe COVID-19 Patients
Published: 2021-10-27 (Crawled : 19:00) - globenewswire.com
SRNE | $0.015 -8.85% 56K
|
Health Technology
|
| O: 0.3%
H: 5.22%
C: 5.07%
covid treatment phase 2 results
Monopar Announces First Patient Dosed in Phase 1b Trial Evaluating Camsirubicin for the Treatment of Advanced Soft Tissue Sarcoma
Published: 2021-10-27 (Crawled : 13:15) - biospace.com/
MNPR | $0.63 -3.08% -3.17% 39K
|
Health Technology
|
| O: 4.88%
H: 7.64%
C: 3.31%
treatment phase 1 phase 1b trial phase 2b soft tissue
Pasithea Therapeutics Announces Successful Treatment of First Patients in the UK with Ketamine Infusion Therapy– Pasithea Clinics
Published: 2021-10-27 (Crawled : 12:15) - biospace.com/
KTTA | $7.09 -1.19% 910
|
|
| O: 2.95%
H: 43.37%
C: 6.09%
treatment therapy ketamine depression
Biohaven Enrolls Phase 1a/1b Clinical Trial of BHV-1100, Lead Asset from its ARM™ (Antibody Recruiting Molecule) Platform, in Combination with NK Cell Therapy for the Treatment of Multiple Myeloma
Published: 2021-10-27 (Crawled : 12:00) - prnewswire.com
BHVN | News 0 d | $38.72 -2.25% -0.28% 970K
|
Health Technology
|
| O: 0.21%
H: 0.1%
C: -3.26%
treatment phase 1 therapy antibody trial phase 1b enroll
AZSTARYS®, An Innovative ADHD Treatment Developed by KemPharm, to be Featured in a Poster Presentation at the 2021 Psych Congress
Published: 2021-10-27 (Crawled : 12:00) - kempharm.com
KMPH | $5.46 6.04% 0
|
Manufacturing
|
| O: -0.39%
H: 2.25%
C: -1.17%
presentation treatment adhd
Merck Presents New Data from Ongoing Phase 2b Clinical Trial Evaluating Efficacy and Safety of Investigational Islatravir in Combination With Doravirine Through 144 Weeks for HIV-1 Treatment at EACS 2021
Published: 2021-10-27 (Crawled : 12:00) - biospace.com/
MRK | $127.0 0.1% -1.21% 7.1M
|
Health Technology
|
| O: 0.71%
H: 0.0%
C: -1.14%
treatment phase 2 ongoing phase 2b trial hiv
Pasithea Therapeutics Announces Successful Treatment of First Patients in the UK with Ketamine Infusion Therapy
Published: 2021-10-27 (Crawled : 12:00) - globenewswire.com
KTTA | $7.09 -1.19% 910
|
|
| O: 2.95%
H: 43.37%
C: 6.09%
treatment therapy ketamine
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.